3-32484064-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000205636.4(CMTM6):c.448C>T(p.Leu150Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000505 in 1,604,340 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000205636.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CMTM6 | NM_017801.3 | c.448C>T | p.Leu150Phe | missense_variant | 4/4 | ENST00000205636.4 | NP_060271.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CMTM6 | ENST00000205636.4 | c.448C>T | p.Leu150Phe | missense_variant | 4/4 | 1 | NM_017801.3 | ENSP00000205636 | P1 | |
CMTM6 | ENST00000478886.1 | n.478C>T | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152080Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000123 AC: 30AN: 243342Hom.: 0 AF XY: 0.000144 AC XY: 19AN XY: 131892
GnomAD4 exome AF: 0.0000510 AC: 74AN: 1452260Hom.: 0 Cov.: 30 AF XY: 0.0000553 AC XY: 40AN XY: 722702
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152080Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74288
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 18, 2023 | The c.448C>T (p.L150F) alteration is located in exon 4 (coding exon 4) of the CMTM6 gene. This alteration results from a C to T substitution at nucleotide position 448, causing the leucine (L) at amino acid position 150 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at